Emerson Electric (EMR) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
4 Nov, 2026Executive summary
Q4 underlying orders rose 14%; underlying sales increased 7%, adjusted segment EBITA margin expanded 160 bps to 29.1%, and adjusted EPS rose 15% to $1.86.
FY26 underlying sales grew 4% and reported sales increased 5% to $18.982B; adjusted EPS rose 10% to $6.59.
FY27 guidance targets ~5% underlying sales growth, 29% adjusted segment EBITA margin, and $7.25 adjusted EPS; orders and backlog support the outlook, while Europe and China temper expectations.
Financial highlights
Q4 net sales were $5.201B versus $4.855B; FY26 net sales were $18.982B versus $18.016B.
FY26 adjusted segment EBITA margin was 28.2%, up 60 bps; adjusted EPS of $6.59 marked the sixth consecutive year of double-digit growth.
FY26 free cash flow was $3.535B, up 9%, with an 18.6% margin; Q4 free cash flow was $916M, up 9%, with a 17.6% margin.
Q4 corporate costs were ~$45M above plan, with a ~$0.05 EPS impact offset by lower interest and share count and tax benefits; most costs are not expected to recur.
Outlook and guidance
FY27 guidance: ~5% underlying sales growth, 29% adjusted segment EBITA margin (+80 bps), adjusted EPS of $7.25 (+10%), and free cash flow of $3.8B-$3.9B.
Q1 FY27 guidance: ~5% underlying sales growth, 28% adjusted segment EBITA margin, and adjusted EPS of $1.58-$1.62.
FY27 planned pricing is 2%; favorable price-cost is expected to offset inflation, while startup costs and mix weigh on first-half margins.
Growth verticals are expected to rise at a low-double-digit pace; power and LNG are projected at the higher end, life sciences at high single digits, and semiconductors at mid-single digits.
Regional outlook: Americas mid-single-digit growth, Europe low single digits, and Asia/Middle East/Africa mid-single digits; assumptions include no China recovery and no escalation of Middle East conflict.
Latest events from Emerson Electric
- Q3 2026 delivered strong growth, margin expansion, and raised full-year guidance.EMR
Q3 2026 - Director elections, compensation, and auditor ratification passed; board declassification failed.EMR
AGM 2026 - Q2 sales and EPS rose, led by Test & Measurement, with robust 2026 outlook and capital returns.EMR
Q2 2026 - Order growth, AI-driven automation, and software rebound underpin strong long-term outlook.EMR
JPMorgan Industrials Conference 2026 - AI-driven software growth and robust U.S. demand fuel strong performance and future outlook.EMR
Citi's Global Industrial Tech & Mobility Conference 2026 - Q1 2026 delivered 4% sales growth, 6% EPS growth, and raised guidance on strong automation demand.EMR
Q1 2026 - Targeting $21B sales, 30% EBITA margin, $8.00 EPS, and $10B shareholder returns by 2028.EMR
Investor Update - Proposing full AspenTech acquisition, reviewing Safety & Productivity sale, and boosting shareholder returns.EMR
Q4 2024 - Q3 sales rose 11%, adjusted EPS up 11%, and Copeland exit boosted debt reduction plans.EMR
Q3 2024